1992
|
Sign up to set email alerts
Bone Mineral Content in Sarcoidosis
Search citation statements
Order By: Relevance
Paper Sections
Select...
12
1
1
0
Citation Types
0
14
0
0
Year Published
Range
1998
19982025
2025Publication Types
Select...
11
2
Relationship
0
13
Authors
Journals
Cited by 13 publications
(14 citation statements)
References 42 publications
0
14
0
0
Order By: Relevance
Smart CitationsHow the paper below cites the one you are viewing
“…The details of diseases or conditions were not elaborated in both studies. 30,34 Even so, there was no significant difference in vBMD at the radius in Tervonen et al 34 study. Notably, Hamada et al, 29 Rizzato et al, 30 and Tervonen et al 34 measured their sarcoidosis patients' BMDs before treatment with corticosteroids.…”
Section: Results
mentioning
confidence: 81%
“…While two studies by Rizzato et al 27,31 did not report patients' comorbid diseases, exclusion of comorbidities, or the drugs that were used in patients with sarcoidosis, their other study 30 reported that there were no diseases or conditions other than menopausal status in their patient group. Patients using hormone therapy, vitamin D, or other drugs known to affect calcium metabolism were also excluded.…”
Section: Results
mentioning
confidence: 98%
“…Among nine eligible studies that were included in the meta-analysis, three studies reported fragility fracture or osteoporotic fracture; 17,18,28 six studies reported vBMD or aBMD. [29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids.…”
Section: Results
mentioning
confidence: 99%
“…[29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids. The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies.…”
Section: Results
mentioning
confidence: 99%
“…The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies. The characteristics of the 10 extracted studies 17,18,[27][28][29][30][31][32][33][34] included in this review were outlined in Table 1. The search methodology and selection process were detailed in the Figure 1.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…The details of diseases or conditions were not elaborated in both studies. 30,34 Even so, there was no significant difference in vBMD at the radius in Tervonen et al 34 study. Notably, Hamada et al, 29 Rizzato et al, 30 and Tervonen et al 34 measured their sarcoidosis patients' BMDs before treatment with corticosteroids.…”
Section: Results
mentioning
confidence: 81%
“…While two studies by Rizzato et al 27,31 did not report patients' comorbid diseases, exclusion of comorbidities, or the drugs that were used in patients with sarcoidosis, their other study 30 reported that there were no diseases or conditions other than menopausal status in their patient group. Patients using hormone therapy, vitamin D, or other drugs known to affect calcium metabolism were also excluded.…”
Section: Results
mentioning
confidence: 98%
“…Among nine eligible studies that were included in the meta-analysis, three studies reported fragility fracture or osteoporotic fracture; 17,18,28 six studies reported vBMD or aBMD. [29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids.…”
Section: Results
mentioning
confidence: 99%
“…[29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids. The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies.…”
Section: Results
mentioning
confidence: 99%
“…The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies. The characteristics of the 10 extracted studies 17,18,[27][28][29][30][31][32][33][34] included in this review were outlined in Table 1. The search methodology and selection process were detailed in the Figure 1.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…The details of diseases or conditions were not elaborated in both studies. 30,34 Even so, there was no significant difference in vBMD at the radius in Tervonen et al 34 study. Notably, Hamada et al, 29 Rizzato et al, 30 and Tervonen et al 34 measured their sarcoidosis patients' BMDs before treatment with corticosteroids.…”
Section: Results
mentioning
confidence: 81%
“…While two studies by Rizzato et al 27,31 did not report patients' comorbid diseases, exclusion of comorbidities, or the drugs that were used in patients with sarcoidosis, their other study 30 reported that there were no diseases or conditions other than menopausal status in their patient group. Patients using hormone therapy, vitamin D, or other drugs known to affect calcium metabolism were also excluded.…”
Section: Results
mentioning
confidence: 98%
“…Among nine eligible studies that were included in the meta-analysis, three studies reported fragility fracture or osteoporotic fracture; 17,18,28 six studies reported vBMD or aBMD. [29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids.…”
Section: Results
mentioning
confidence: 99%
“…[29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids. The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies.…”
Section: Results
mentioning
confidence: 99%
“…The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies. The characteristics of the 10 extracted studies 17,18,[27][28][29][30][31][32][33][34] included in this review were outlined in Table 1. The search methodology and selection process were detailed in the Figure 1.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…The details of diseases or conditions were not elaborated in both studies. 30,34 Even so, there was no significant difference in vBMD at the radius in Tervonen et al 34 study. Notably, Hamada et al, 29 Rizzato et al, 30 and Tervonen et al 34 measured their sarcoidosis patients' BMDs before treatment with corticosteroids.…”
Section: Results
mentioning
confidence: 81%
“…While two studies by Rizzato et al 27,31 did not report patients' comorbid diseases, exclusion of comorbidities, or the drugs that were used in patients with sarcoidosis, their other study 30 reported that there were no diseases or conditions other than menopausal status in their patient group. Patients using hormone therapy, vitamin D, or other drugs known to affect calcium metabolism were also excluded.…”
Section: Results
mentioning
confidence: 98%
“…Among nine eligible studies that were included in the meta-analysis, three studies reported fragility fracture or osteoporotic fracture; 17,18,28 six studies reported vBMD or aBMD. [29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids.…”
Section: Results
mentioning
confidence: 99%
“…[29][30][31][32][33][34] Sarcoidosis participants that were on glucocorticoids were excluded from two studies; 29,34 BMD was measured before initiation of glucocorticoids in one studies. 30 Meanwhile, those studies that reported fracture as an outcome 17,18,28 have stratified the risk of fracture based on average, duration or cumulative dose of glucocorticoids. The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies.…”
Section: Results
mentioning
confidence: 99%
“…The inclusion or exclusion of participants that were on treatment or prevention of bone loss with osteoporotic medications varied between studies. The characteristics of the 10 extracted studies 17,18,[27][28][29][30][31][32][33][34] included in this review were outlined in Table 1. The search methodology and selection process were detailed in the Figure 1.…”
Section: Results
mentioning
confidence: 99%
Abstract